Oklahoma § 63-427.18 - Packaging and labeling requirements

§ 63-427.18. Packaging and labeling requirements

A. A medical marijuana business shall not sell, transfer or

otherwise distribute medical marijuana or medical marijuana product

that has not been packaged and labeled in accordance with this

Oklahoma Statutes - Title 63. Public Health and Safety

section and rules promulgated by the Executive Director of the

Oklahoma Medical Marijuana Authority.

B. A medical marijuana dispensary shall return medical

marijuana and medical marijuana product that does not meet packaging

or labeling requirements in this section or rules promulgated

pursuant thereto to the entity who transferred it to the dispensary.

The medical marijuana dispensary shall document to whom the item was

returned, what was returned, and the date of the return, or dispose

of any usable marijuana that does not meet these requirements in

accordance with the Oklahoma Medical Marijuana and Patient

Protection Act.

C. 1. Medical marijuana packaging shall be packaged to

minimize its appeal to children and shall not depict images other

than the business name logo of the medical marijuana producer and

image of the product.

2. A medical marijuana business shall not place any content on

a container in a manner that reasonably appears to target

individuals under the age of twenty-one (21) including, but not

limited to, cartoon characters or similar images.

3. Labels on a container shall not include any false or

misleading statements.

4. No container shall be intentionally or knowingly labeled so

as to cause a reasonable patient confusion as to whether the medical

marijuana, medical marijuana concentrate or medical marijuana

product is a trademarked product or labeled in a manner that

violates any federal trademark law or regulation. The label on the

container shall include a warning that states the following:

a.

“For use by licensed medical marijuana patients only”,

b.

“Keep out of reach of children”,

c.

“It is illegal to drive a motor vehicle while under

the influence of marijuana or marijuana products”,

d.

“Women should not use marijuana or marijuana products

during pregnancy because of the risk of birth

defects”, and

e.

“This product has been tested for contaminants”.

5. The label on the container shall not make any claims

regarding health or physical benefits to the patient.

6. The container itself may be clear in order to allow licensed

medical marijuana patients and licensed medical marijuana caregivers

the ability to view the product inside the container but shall be

child-resistant, as defined in Section 427.2 of this title.

7. At the point of sale and transfer of any medical marijuana,

medical marijuana concentrate, or medical marijuana products to a

licensed medical marijuana patient or licensed medical marijuana

caregiver, the dispensary shall place the medical marijuana, medical

marijuana concentrate, or medical marijuana products in an exit

package, as such term is defined in Section 427.2 of this title.

Oklahoma Statutes - Title 63. Public Health and Safety

D. The Executive Director shall develop minimum standards for

packaging and labeling of medical marijuana, medical marijuana

concentrate, and medical marijuana products. Such standards shall

include, but not be limited to, the required contents of labels to

be affixed to all medical marijuana, medical marijuana concentrate,

and medical marijuana products prior to transfer to a licensed

patient or caregiver, which shall include, at a minimum:

1. THC and other cannabinoid potency, and terpenoid potency;

2. A statement indicating that the product has been tested for

contaminants;

3. One or more product warnings to be determined by the

Executive Director; and

4. Any other information the Executive Director deems

necessary.

Added by Laws 2019, c. 11, § 18. Amended by Laws 2021, c. 553, §

20, eff. Nov. 1, 2021; Laws 2022, c. 141, § 2, eff. Nov. 1, 2022;

Laws 2024, c. 452, § 144, emerg. eff. June 14, 2024; Laws 2025, c.

272, § 1, eff. Nov. 1, 2025.